GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects a multi-blockbuster ...

Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...

At a recent Community Case Forum, he discussed the use of CAR T-cell therapies for patients with multiple myeloma. He ...

The department used its new system for determining whether a condition is service-connected to give affected veterans access ...

The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.

Barry was first diagnosed with solitary plasmacytoma myeloma in 2010 ... who he married in 1999. Multiple myeloma is a cancer that begins to form in bone marrow. While plasma cells ordinary ...

Credit: Michael Vi/Shutterstock The European label for Johnson and Johnson Innovation Medicine’s (J&J) Darzalex (daratumumab) has been expanded to include patients with newly diagnosed multiple ...

A 70-year-old white male, who had been diagnosed with IgA lambda multiple myeloma 4 months previously, was referred to the Mayo Clinic for further evaluation of anemia. The patient had required ...